New book for Wiley on the horizon—disruptive innovation for Big Pharma?

Don't rule it out...

This is about the second book for Wiley!

I’m incredibly pleased to report that a new book of mine, to be published by Wiley, Hoboken, NJ, is on the horizon.

A few weeks ago, I received an email from the editor of my first book for Wiley, titled Supply Chain Management in the Drug Industry: Delivering Patient Value for Pharmaceuticals and Biologics, (published 2011), asking if I would consider writing a follow-on book.

If I had been approached prior to C19, it would have seemed pointless, as the audience Inside Pharma was all but exhausted. In fact, the preface to Find It, File It, Flog It: Pharma’s Crippling Addiction and How to Cure It (2015), I described pharma as “an industry where the topic of professional management of end-to-end supply chains was as popular as the Conservative Club in Moscow.”

However, the last three years has changed the landscape dramatically. It seems to me (am I alone?) that there is rising global public concern about the modus operandi of the companies develop…